Browse by Authors and EditorsNumber of items: 4. 2017Ojiegbe, S., Joseph, C., Provenzano, E., Caldas, C., Nolan, C., Green, A.R., Rakha, E., Ellis, I.O. and Mukherjee, A. (2017) Cell division cycle 25C (CDC25C) expression confers poor prognosis in invasive breast cancer. In: Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 June 2017, Belfast, United Kingdom. Ojiegbe, S., Joseph, C., Provenzano, E., Caldas, C., Nolan, C., Green, A.R., Rakha, E., Ellis, I.O. and Mukherjee, A. (2017) Elevated expression of STK3 mRNA and protein is associated with poor outcome in invasive breast cancer. In: Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 June 2017, Belfast, United Kingdom. Aliyeva, T.A., Joseph, C., Provenzano, E., Russell, R., Caldas, C., Sonbul, S., Nolan, C., Green, A.R., Rakha, E.A, Ellis, IO. and Mukherjee, A. (2017) Loss of MED23 leads to poor prognosis in invasive breast cancer. In: Belfast Pathology 2017: 10th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 20-23 June 2017, Belfast, United Kingdom. 2015Aleskandarany, Mohammed A., Soria, D., Green, A.R., Nolan, C., Diez-Rodriguez, Maria, Ellis, Ian O. and Rakha, Emad (2015) Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification. Breast Cancer Research and Treatment, 151 (2). pp. 325-333. ISSN 0167-6806 |